Rituximab and risk of HBV re-activation

[you guys probably give way more rituximab than I do.] You know how you're supposed to get a hepatitis panel before starting rituximab, so what if the panel is positive for the inactive chronic charier state of HBV? (+HBsAg , +HBcAb , but undetectable viral load, normal liver enzymes). Could you still give the rituximab? Or is even the inactive carrier state of HBV (negative PCR, negative LAEs) a contraindication?
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Hematology / Oncology Source Type: forums